Jun 29, 2025 Metagen Therapeutics and FRONTEO Launch Joint Research on Globally Watched Microbiome Drug Discovery Analyzing the Actions and Disease Associations of Gut Microbiota Using the Drug Discovery AI Factory
Jun 24, 2025 FRONTEO Accelerates U.S. Expansion — Signs Strategic Partnership Agreement with U.S.-based Q Partners, a Firm with Strengths in Life Sciences and Technology
May 14, 2025 FRONTEO and Chugai Pharmaceutical launch co-creation project for target discovery utilizing Drug Discovery AI Factory Accelerating R&D to Achieve First-in-Class and Best-in-Class Products Through Proprietary Technology That Systematically Discovers Unknown Disease–Molecule Correlations from Known Literature information.
May 12, 2025 FRONTEO and Institute of Science Tokyo Launch Joint Research on New Drug Discovery Targets Using the Drug Discovery AI Factory Verifying AI-Detected Drug Targets Through Both Dry and Wet Research to Develop Medicines Addressing Unmet Medical Needs
May 11, 2025 EA Pharma and FRONTEO Launch Co-Creation Project for AI-Powered Target Discovery in Drug Development
May 7, 2025 Making the Pharmaceutical Industry a Core Industry in Japan: Launch of the “FRONTEO Co-creation Drug Discovery Ecosystem” Centered on the AI-driven drug discovery support service “Drug Discovery AI Factory,” the company aims to solve drug discovery challenges and create innovative pharmaceuticals through collaboration with diverse co-creation partners
Jan 27, 2025 FRONTEO and Eisai launch co-creation project for target discovery using Drug Discovery AI Factory Accelerate First in Class R&D with FRONTEO’s unique technologies that systematically discover unreported relationships between diseases and molecules from existing literature information.
Jan 15, 2025 Publication of White Paper on innovative drug discovery approach using Springer Nature’s literature data and FRONTEO’s specialized AI engine KIBIT FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
Jan 8, 2025 FRONTEO and Maruishi Pharmaceutical launch co-creation project for biomarker discovery using Drug Discovery AI Factory Accelerate pharmaceutical research and development with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature.
Dec 16, 2024 Skadden Arps Slate Meagher & Flom LLP and Affiliates Webinar Report December 17, 2024 Share On 11th Dec (ET), in collaboration with Skadden Arps Slate Meagher & Flom LLP and Affiliates, FRONTEO hosted a free webinar on “Reinsurance boom and recent trend of Japan life insurance/annuity market and best structure for Japanese insurance companies”. Akira Kumaki and Elena M. Coyle from...
Nov 13, 2024 UBE and FRONTEO launch co-creation project for drug repositioning using Drug Discovery AI Factory Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
Nov 11, 2024 FRONTEO and Daiichi Sankyo signed an agreement for optimization and analysis of toxicity information with Drug Discovery AI Factory Supporting the construction of innovative AI discovery systems to derive new findings from toxicity study database and toxicity study reports
